IBDEI0E6 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19152,0)
 ;;=726.10^^119^1152^12
 ;;^UTILITY(U,$J,358.3,19152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19152,1,4,0)
 ;;=4^726.10
 ;;^UTILITY(U,$J,358.3,19152,1,5,0)
 ;;=5^Rotator Cuff Syndrome
 ;;^UTILITY(U,$J,358.3,19152,2)
 ;;=^272523
 ;;^UTILITY(U,$J,358.3,19153,0)
 ;;=135.^^119^1152^13
 ;;^UTILITY(U,$J,358.3,19153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19153,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,19153,1,5,0)
 ;;=5^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,19153,2)
 ;;=^107916
 ;;^UTILITY(U,$J,358.3,19154,0)
 ;;=710.1^^119^1152^14
 ;;^UTILITY(U,$J,358.3,19154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19154,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,19154,1,5,0)
 ;;=5^Scleroderma
 ;;^UTILITY(U,$J,358.3,19154,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,19155,0)
 ;;=995.20^^119^1152^1
 ;;^UTILITY(U,$J,358.3,19155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19155,1,4,0)
 ;;=4^995.20
 ;;^UTILITY(U,$J,358.3,19155,1,5,0)
 ;;=5^Adverse Effects of Meds
 ;;^UTILITY(U,$J,358.3,19155,2)
 ;;=^334208
 ;;^UTILITY(U,$J,358.3,19156,0)
 ;;=V67.51^^119^1152^6
 ;;^UTILITY(U,$J,358.3,19156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19156,1,4,0)
 ;;=4^V67.51
 ;;^UTILITY(U,$J,358.3,19156,1,5,0)
 ;;=5^Hi-Risk F/U Exam
 ;;^UTILITY(U,$J,358.3,19156,2)
 ;;=^295577
 ;;^UTILITY(U,$J,358.3,19157,0)
 ;;=136.1^^119^1153^1
 ;;^UTILITY(U,$J,358.3,19157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19157,1,4,0)
 ;;=4^136.1
 ;;^UTILITY(U,$J,358.3,19157,1,5,0)
 ;;=5^Behcet's Syndrome
 ;;^UTILITY(U,$J,358.3,19157,2)
 ;;=^13205
 ;;^UTILITY(U,$J,358.3,19158,0)
 ;;=710.3^^119^1153^2
 ;;^UTILITY(U,$J,358.3,19158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19158,1,4,0)
 ;;=4^710.3
 ;;^UTILITY(U,$J,358.3,19158,1,5,0)
 ;;=5^Dermatomyositis
 ;;^UTILITY(U,$J,358.3,19158,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,19159,0)
 ;;=710.9^^119^1153^3
 ;;^UTILITY(U,$J,358.3,19159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19159,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,19159,1,5,0)
 ;;=5^Diff Connect Tis Dis NOS
 ;;^UTILITY(U,$J,358.3,19159,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,19160,0)
 ;;=710.5^^119^1153^4
 ;;^UTILITY(U,$J,358.3,19160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19160,1,4,0)
 ;;=4^710.5
 ;;^UTILITY(U,$J,358.3,19160,1,5,0)
 ;;=5^Eosinophilia Myalgia
 ;;^UTILITY(U,$J,358.3,19160,2)
 ;;=^184796
 ;;^UTILITY(U,$J,358.3,19161,0)
 ;;=710.8^^119^1153^5
 ;;^UTILITY(U,$J,358.3,19161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19161,1,4,0)
 ;;=4^710.8
 ;;^UTILITY(U,$J,358.3,19161,1,5,0)
 ;;=5^Mixed Connect Tis Dis NEC
 ;;^UTILITY(U,$J,358.3,19161,2)
 ;;=^271945
 ;;^UTILITY(U,$J,358.3,19162,0)
 ;;=710.4^^119^1153^6
 ;;^UTILITY(U,$J,358.3,19162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19162,1,4,0)
 ;;=4^710.4
 ;;^UTILITY(U,$J,358.3,19162,1,5,0)
 ;;=5^Polymyositis
 ;;^UTILITY(U,$J,358.3,19162,2)
 ;;=^186822
 ;;^UTILITY(U,$J,358.3,19163,0)
 ;;=710.2^^119^1153^7
 ;;^UTILITY(U,$J,358.3,19163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19163,1,4,0)
 ;;=4^710.2
 ;;^UTILITY(U,$J,358.3,19163,1,5,0)
 ;;=5^Sjogren Syndrome
 ;;^UTILITY(U,$J,358.3,19163,2)
 ;;=^192145
 ;;^UTILITY(U,$J,358.3,19164,0)
 ;;=710.0^^119^1153^8
 ;;^UTILITY(U,$J,358.3,19164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19164,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,19164,1,5,0)
 ;;=5^Syst Lupus Erythematosis
 ;;^UTILITY(U,$J,358.3,19164,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,19165,0)
 ;;=710.1^^119^1153^9
 ;;^UTILITY(U,$J,358.3,19165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19165,1,4,0)
 ;;=4^710.1
 ;;^UTILITY(U,$J,358.3,19165,1,5,0)
 ;;=5^Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,19165,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,19166,0)
 ;;=V79.0^^120^1154^5
 ;;^UTILITY(U,$J,358.3,19166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19166,1,4,0)
 ;;=4^V79.0
 ;;^UTILITY(U,$J,358.3,19166,1,5,0)
 ;;=5^SCREENING FOR DEPRESSION
 ;;^UTILITY(U,$J,358.3,19166,2)
 ;;=^295677
 ;;^UTILITY(U,$J,358.3,19167,0)
 ;;=V79.1^^120^1154^4
 ;;^UTILITY(U,$J,358.3,19167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19167,1,4,0)
 ;;=4^V79.1
 ;;^UTILITY(U,$J,358.3,19167,1,5,0)
 ;;=5^SCREENING FOR ALCOHOLISM
 ;;^UTILITY(U,$J,358.3,19167,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,19168,0)
 ;;=V79.2^^120^1154^3
 ;;^UTILITY(U,$J,358.3,19168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19168,1,4,0)
 ;;=4^V79.2
 ;;^UTILITY(U,$J,358.3,19168,1,5,0)
 ;;=5^SCREEN-MENTAL RETARDAT
 ;;^UTILITY(U,$J,358.3,19168,2)
 ;;=^340656
 ;;^UTILITY(U,$J,358.3,19169,0)
 ;;=V79.3^^120^1154^1
 ;;^UTILITY(U,$J,358.3,19169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19169,1,4,0)
 ;;=4^V79.3
 ;;^UTILITY(U,$J,358.3,19169,1,5,0)
 ;;=5^SCREEN-DEVELOPMENT PROB
 ;;^UTILITY(U,$J,358.3,19169,2)
 ;;=^295680
 ;;^UTILITY(U,$J,358.3,19170,0)
 ;;=V79.8^^120^1154^2
 ;;^UTILITY(U,$J,358.3,19170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19170,1,4,0)
 ;;=4^V79.8
 ;;^UTILITY(U,$J,358.3,19170,1,5,0)
 ;;=5^SCREEN-MENTAL DIS NEC
 ;;^UTILITY(U,$J,358.3,19170,2)
 ;;=^295681
 ;;^UTILITY(U,$J,358.3,19171,0)
 ;;=V10.00^^120^1155^9
 ;;^UTILITY(U,$J,358.3,19171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19171,1,4,0)
 ;;=4^V10.00
 ;;^UTILITY(U,$J,358.3,19171,1,5,0)
 ;;=5^HX OF GI MALIGNANCY NOS
 ;;^UTILITY(U,$J,358.3,19171,2)
 ;;=^295202
 ;;^UTILITY(U,$J,358.3,19172,0)
 ;;=V10.01^^120^1155^21
 ;;^UTILITY(U,$J,358.3,19172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19172,1,4,0)
 ;;=4^V10.01
 ;;^UTILITY(U,$J,358.3,19172,1,5,0)
 ;;=5^HX OF TONGUE MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19172,2)
 ;;=^295203
 ;;^UTILITY(U,$J,358.3,19173,0)
 ;;=V10.02^^120^1155^38
 ;;^UTILITY(U,$J,358.3,19173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19173,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,19173,1,5,0)
 ;;=5^HX-ORAL/PHARYNX MALG NEC
 ;;^UTILITY(U,$J,358.3,19173,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,19174,0)
 ;;=V10.03^^120^1155^25
 ;;^UTILITY(U,$J,358.3,19174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19174,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,19174,1,5,0)
 ;;=5^HX-ESOPHAGEAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19174,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,19175,0)
 ;;=V10.04^^120^1155^7
 ;;^UTILITY(U,$J,358.3,19175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19175,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,19175,1,5,0)
 ;;=5^HX OF GASTRIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19175,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,19176,0)
 ;;=V10.05^^120^1155^5
 ;;^UTILITY(U,$J,358.3,19176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19176,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,19176,1,5,0)
 ;;=5^HX OF COLONIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19176,2)
 ;;=^295207
 ;;^UTILITY(U,$J,358.3,19177,0)
 ;;=V10.06^^120^1155^40
 ;;^UTILITY(U,$J,358.3,19177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19177,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,19177,1,5,0)
 ;;=5^HX-RECTAL ANAL MALIGN
 ;;^UTILITY(U,$J,358.3,19177,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,19178,0)
 ;;=V10.07^^120^1155^13
 ;;^UTILITY(U,$J,358.3,19178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19178,1,4,0)
 ;;=4^V10.07
 ;;^UTILITY(U,$J,358.3,19178,1,5,0)
 ;;=5^HX OF LIVER MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19178,2)
 ;;=^295209
 ;;^UTILITY(U,$J,358.3,19179,0)
 ;;=V10.09^^120^1155^8
 ;;^UTILITY(U,$J,358.3,19179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19179,1,4,0)
 ;;=4^V10.09
 ;;^UTILITY(U,$J,358.3,19179,1,5,0)
 ;;=5^HX OF GI MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,19179,2)
 ;;=^295210
 ;;^UTILITY(U,$J,358.3,19180,0)
 ;;=V10.11^^120^1155^22
 ;;^UTILITY(U,$J,358.3,19180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19180,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,19180,1,5,0)
 ;;=5^HX-BRONCHOGENIC MALIGNAN
 ;;^UTILITY(U,$J,358.3,19180,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,19181,0)
 ;;=V10.12^^120^1155^44
 ;;^UTILITY(U,$J,358.3,19181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19181,1,4,0)
 ;;=4^V10.12
 ;;^UTILITY(U,$J,358.3,19181,1,5,0)
 ;;=5^HX-TRACHEAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19181,2)
 ;;=^295212
 ;;^UTILITY(U,$J,358.3,19182,0)
 ;;=V10.20^^120^1155^41
 ;;^UTILITY(U,$J,358.3,19182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19182,1,4,0)
 ;;=4^V10.20
 ;;^UTILITY(U,$J,358.3,19182,1,5,0)
 ;;=5^HX-RESP ORG MALIGNAN NOS
 ;;^UTILITY(U,$J,358.3,19182,2)
 ;;=^295213
 ;;^UTILITY(U,$J,358.3,19183,0)
 ;;=V10.21^^120^1155^30
 ;;^UTILITY(U,$J,358.3,19183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19183,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,19183,1,5,0)
 ;;=5^HX-LARYNGEAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19183,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,19184,0)
 ;;=V10.22^^120^1155^37
 ;;^UTILITY(U,$J,358.3,19184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19184,1,4,0)
 ;;=4^V10.22
 ;;^UTILITY(U,$J,358.3,19184,1,5,0)
 ;;=5^HX-NOSE/EAR/SINUS MALIG
 ;;^UTILITY(U,$J,358.3,19184,2)
 ;;=^295215
 ;;^UTILITY(U,$J,358.3,19185,0)
 ;;=V10.29^^120^1155^29
 ;;^UTILITY(U,$J,358.3,19185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19185,1,4,0)
 ;;=4^V10.29
 ;;^UTILITY(U,$J,358.3,19185,1,5,0)
 ;;=5^HX-INTRATHORACIC MAL NEC
 ;;^UTILITY(U,$J,358.3,19185,2)
 ;;=^295216
 ;;^UTILITY(U,$J,358.3,19186,0)
 ;;=V10.3^^120^1155^4
 ;;^UTILITY(U,$J,358.3,19186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19186,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,19186,1,5,0)
 ;;=5^HX OF BREAST MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19186,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,19187,0)
 ;;=V10.40^^120^1155^27
 ;;^UTILITY(U,$J,358.3,19187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19187,1,4,0)
 ;;=4^V10.40
 ;;^UTILITY(U,$J,358.3,19187,1,5,0)
 ;;=5^HX-FEMALE GENIT MALG NOS
 ;;^UTILITY(U,$J,358.3,19187,2)
 ;;=^295218
 ;;^UTILITY(U,$J,358.3,19188,0)
 ;;=V10.41^^120^1155^23
 ;;^UTILITY(U,$J,358.3,19188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19188,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,19188,1,5,0)
 ;;=5^HX-CERVICAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,19188,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,19189,0)
 ;;=V10.42^^120^1155^47
